Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40
Published November 22, 2017 · Recall initiated: October 13, 2017
Summary
FDA records drug Class II recall D-0080-2018, published November 22, 2017 and initiated October 13, 2017. Recalling firm: PharMEDium Services, LLC.; Status: Terminated; Reported quantity: 499 syringes; Lot: Lot#: 172820134M, Exp 01/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent drug: out of specification result for potency
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- PharMEDium Services, LLC.
- Distributor
- CA, IL
- Lot
- Lot#: 172820134M, Exp 01/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEstriol, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-1392-1), b) 5 G bottle (NDC:November 22, 2017
- FDAUrin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene BlueNovember 22, 2017
- FDALumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC#November 22, 2017
- FDAMeclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: JubilantNovember 22, 2017
- FDACombigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mLNovember 22, 2017
- FDABrightFarms Baby Spinach (4 oz. and 8 oz., and 3# packages)November 22, 2017
Questions about this recall
Was Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40 recalled?
Yes. FDA published recall D-0080-2018 on November 22, 2017. Reported hazard: Superpotent drug: out of specification result for potency
What should I do if I have this product?
Voluntary: Firm initiated · Telephone